Blood pressure recordings were performed by the Telemetry Unit for Cardiovascular Phenotyping at the University of Copenhagen, supported by the Novo Nordisk Foundation (grant number NNF18OC0032728 to M.B.T.)
Phase 1 and Early Development Phase 1 studies in healthy volunteers established proof-of-concept, demonstrating that retatrutide was well-tolerated and produced dose-dependent effects on appetite, food intake, and body weight with acceptable safety profiles
The medication supports that process, but long-term success still comes from the habits people build alongside it. Jason Murphy, Head of Pharmacy at Chemist4U Long-term safety concerns remain high More than one in five ( 23.01% ) respondents said concerns about long-term safety or usage stopped them from pursuing GLP-1 treatments
GLP-1 and GIP are incretin hormones that have been shown to influence insulin secretion, appetite, and glycemic control, while GCG primarily stimulates lipolysis, increases energy expenditure, and promotes fatty acid oxidation
But the new study offers some of the first large-scale evidence on what happens to patients' hearts when they quit these drugs, particularly among those with diabetes
Letzteres ist eng mit der Entwicklung einer Myokarditis verknpft
